Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027224
Filing Date
2024-11-19
Accepted
2024-11-19 16:30:20
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 form4-11192024_091114.html 4  
1 form4-11192024_091114.xml 4 15274
  Complete submission text file 0001415889-24-027224.txt   16854
Mailing Address 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746
Business Address
York Charles N II (Reporting) CIK: 0001655962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40431 | Film No.: 241476638

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Issuer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)